We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Wants More Information Before It Will OK Ablatherm
FDA Wants More Information Before It Will OK Ablatherm
The FDA wants additional data and a revised indication for use before it will approve an ultrasound treatment for prostate cancer, according to an unapprovable letter sent to French devicemaker EDAP.